Lee, Jii Bum <br/><br/>
Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial.  [electronic resource] 

 -  Trials  Apr 2020 
 - 320 p.  digital 
<br/><br/> Publication Type: Clinical Trial Protocol; Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1745-6215 
<br/><br/><label>Standard No.: </label>10.1186/s13063-020-04266-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Chemoradiotherapy--methods<br/>Chemotherapy, Adjuvant<br/>Clinical Trials, Phase II as Topic<br/>Disease-Free Survival<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Fluorouracil--therapeutic use<br/>Humans<br/>Leucovorin--therapeutic use<br/>Multicenter Studies as Topic<br/>Neoadjuvant Therapy--methods<br/>Neoplasm Invasiveness<br/>Neoplasm Staging<br/>Organoplatinum Compounds--therapeutic use<br/>Preoperative Care--methods<br/>Prognosis<br/>Prospective Studies<br/>Randomized Controlled Trials as Topic<br/>Rectal Neoplasms--drug therapy<br/>Republic of Korea<br/>Survival Analysis<br/>Treatment Outcome